International Flavors & Fragrances Inc (NYSE:IFF) Signals Upward Momentum With Margin Recovery Driving Near-Term Bias

Portfolio pruning and operational gains place IFF on a constructive near-term trajectory while margin expansion and cash generation determine the pace and scope of any sustained move.

Recent News

On Feb. 11, 2026 the company launched a formal sale process for its Food Ingredients business; the Board also declared a quarterly cash dividend. The Soy Crush, Concentrates and Lecithin group closed as a divestiture in early March 2026; management continues disciplined portfolio refinement and confirmed corporate participation at industry events in April.

Technical Analysis

Directional indicators show an emerging trend: ADX at 23.42 signals trend emergence while DI+ at 30.57 (dip-and-reversal) registered bullish pressure and DI- at 17.7 (decreasing) removed downside bias; those readings align with a near-term positive price bias tied to operational catalysts.

MACD sits at 1.43 with the MACD line above the signal line (signal 0.52) and the MACD trend increasing; the cross above the signal line constitutes a bullish momentum confirmation that supports the case for further upside toward short-term targets.

MRO reads 28.59 and increases, indicating the market price sits above the regression target and that upward momentum may face mean-reversion pressure; the magnitude suggests a moderate potential for consolidation or pullback from elevated levels.

RSI at 52.6 and rising implies neutral-to-mild bullish momentum without overbought conditions, leaving room for additional advance before typical momentum fatigue emerges.

Price structure favors buyers: the close at $78.47 trades above the 50-day ($72.40) and 200-day ($68.78) averages, and the 12-day EMA shows a dip-and-reversal consistent with short-term recovery. Price nears the upper Bollinger band (upper 1x SD $79.27), so any extension likely finds near-term resistance just above present levels; SuperTrend lower support resides near $74.92. Short-term volatility (42-day beta 1.81) exceeds the 52-week beta (0.88), signaling elevated sensitivity to market moves in the near term.

 


Fundamental Analysis

Profitability and margins: EBIT totaled $253,000,000 and EBITDA $499,000,000. EBIT margin equals 9.23%, below the industry peer mean of 13.48% and below the peer median of 12.41%, indicating margin compression relative to peers despite recent operational actions. Operating margin stands at 10.18%, also below the industry peer mean of 13.93%.

Revenue and earnings: Total revenue reached $2,741,000,000. Reported EPS equaled $1.25 versus an estimate of $1.07, producing an EPS surprise of approximately 16.82% and a beat of $0.18. Reported revenue growth measures include a 5.87% growth figure and a year-over-year revenue growth figure of 125.98%; QoQ revenue slipped (QoQ growth -2.51%).

Cash generation and leverage: Free cash flow totaled $92,000,000 with a free cash flow yield near 0.50%. Cash and short-term investments amount to $562,000,000 while net debt sits at $5,255,000,000, producing a debt-to-EBITDA of ~12.9 and an interest coverage ratio of 5.75. The leverage profile remains material and will influence valuation recovery even as operating cash flow ($394,000,000) supports near-term obligations.

Balance-sheet and efficiency metrics: Current ratio 1.49 and quick ratio 0.84 indicate working-capital tightness versus the industry peer mean current ratio of 2.82. Cash conversion cycle at 115 days sits below the industry peer mean of 154.84 days, reflecting relatively efficient receivables and inventory conversion. Asset turnover registers 0.108, somewhat below the industry peer mean of 0.14786, consistent with a capital-intensive specialty-chemicals footprint.

Valuation multiples: Trailing P/E sits near 57.53 and forward P/E near 59.49; the trailing P/E falls below the industry peer median of 83.08 and well below the peer mean, while price-to-book at 1.30 compares below the industry peer mean of 3.17. Enterprise multiple at 48.55 records below the reported industry peer mean of 59.66. WMDST values the stock as under-valued, reflecting the gap between capital-market multiples and the company’s fundamental cash-generation profile adjusted for leverage.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2026-03-31
REPORT DATE: 2026-05-05
NEXT REPORT DATE: 2026-08-04
CASH FLOW  Begin Period Cash Flow 590.0 M
 Operating Cash Flow 394.0 M
 Capital Expenditures -165.00 M
 Change In Working Capital -162.00 M
 Dividends Paid -102.00 M
 Cash Flow Delta -28.00 M
 End Period Cash Flow 562.0 M
 
INCOME STATEMENT REVENUE
 Total Revenue 2.7 B
 Forward Revenue 1.3 B
COSTS
 Cost Of Revenue 1.7 B
 Depreciation 100.0 M
 Depreciation and Amortization 246.0 M
 Research and Development 166.0 M
 Total Operating Expenses 2.5 B
PROFITABILITY
 Gross Profit 1.0 B
 EBITDA 499.0 M
 EBIT 253.0 M
 Operating Income 279.0 M
 Interest Income 3.0 M
 Interest Expense 44.0 M
 Net Interest Income -41.00 M
 Income Before Tax 209.0 M
 Tax Provision 39.0 M
 Tax Rate 18.66 %
 Net Income 169.0 M
 Net Income From Continuing Operations 170.0 M
EARNINGS
 EPS Estimate 1.07
 EPS Actual 1.25
 EPS Difference 0.18
 EPS Surprise 16.822 %
 Forward EPS 1.21
 
BALANCE SHEET ASSETS
 Total Assets 25.1 B
 Intangible Assets 14.1 B
 Net Tangible Assets 33.0 M
 Total Current Assets 5.4 B
 Cash and Short-Term Investments 562.0 M
 Cash 562.0 M
 Net Receivables 1.8 B
 Inventory 2.4 B
 Long-Term Investments 308.0 M
LIABILITIES
 Accounts Payable 1.4 B
 Short-Term Debt 1.1 B
 Total Current Liabilities 3.6 B
 Net Debt 5.3 B
 Total Debt 6.4 B
 Total Liabilities 11.0 B
EQUITY
 Total Equity 14.1 B
 Retained Earnings -3.35 B
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 55.33
 Shares Outstanding 255.200 M
 Revenue Per-Share 10.74
VALUATION
 Market Capitalization 18.4 B
 Enterprise Value 24.2 B
 Enterprise Multiple 48.547
Enterprise Multiple QoQ -36.953 %
Enterprise Multiple YoY -213.521 %
Enterprise Multiple IPRWA high: 95.48
mean: 59.66
median: 57.259
IFF: 48.547
low: 36.078
 EV/R 8.838
CAPITAL STRUCTURE
 Asset To Equity 1.781
 Asset To Liability 2.288
 Debt To Capital 0.313
 Debt To Assets 0.256
Debt To Assets QoQ -1.25 %
Debt To Assets YoY -27.013 %
Debt To Assets IPRWA high: 0.604
mean: 0.341
median: 0.336
IFF: 0.256
low: 0.109
 Debt To Equity 0.456
Debt To Equity QoQ -2.545 %
Debt To Equity YoY -39.408 %
Debt To Equity IPRWA high: 2.488
median: 0.789
mean: 0.76
IFF: 0.456
low: 0.144
PRICE-BASED VALUATION
 Price To Book (P/B) 1.3
Price To Book QoQ 4.008 %
Price To Book YoY -14.715 %
Price To Book IPRWA high: 4.282
median: 3.266
mean: 3.172
IFF: 1.3
low: 1.093
 Price To Earnings (P/E) 57.529
Price To Earnings QoQ -33.465 %
Price To Earnings YoY -12.084 %
Price To Earnings IPRWA high: 846.689
mean: 170.748
median: 83.078
IFF: 57.529
low: -69.317
 PE/G Ratio 1.023
 Price To Sales (P/S) 6.695
Price To Sales QoQ -1.996 %
Price To Sales YoY -5.211 %
Price To Sales IPRWA high: 34.788
mean: 12.845
median: 9.878
IFF: 6.695
low: 2.295
FORWARD MULTIPLES
Forward P/E 59.495
Forward PE/G 1.058
Forward P/S 14.62
EFFICIENCY OPERATIONAL
 Operating Leverage 43.662
ASSET & SALES
 Asset Turnover Ratio 0.108
Asset Turnover Ratio QoQ 7.174 %
Asset Turnover Ratio YoY 8.301 %
Asset Turnover Ratio IPRWA high: 0.211
median: 0.16
mean: 0.148
IFF: 0.108
low: 0.043
 Receivables Turnover 1.539
Receivables Turnover Ratio QoQ 7.031 %
Receivables Turnover Ratio YoY -8.867 %
Receivables Turnover Ratio IPRWA high: 2.288
median: 1.647
mean: 1.614
IFF: 1.539
low: 0.352
 Inventory Turnover 0.728
Inventory Turnover Ratio QoQ 3.106 %
Inventory Turnover Ratio YoY -6.774 %
Inventory Turnover Ratio IPRWA high: 1.444
mean: 0.907
median: 0.9
IFF: 0.728
low: 0.416
 Days Sales Outstanding (DSO) 59.274
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 115.023
Cash Conversion Cycle Days QoQ -6.657 %
Cash Conversion Cycle Days YoY 8.972 %
Cash Conversion Cycle Days IPRWA high: 332.977
mean: 154.838
IFF: 115.023
median: 107.131
low: 89.724
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 1.53
 CapEx To Revenue -0.06
 CapEx To Depreciation -1.65
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 18.9 B
 Net Invested Capital 19.9 B
 Invested Capital 19.9 B
 Net Tangible Assets 33.0 M
 Net Working Capital 1.8 B
LIQUIDITY
 Cash Ratio 0.154
 Current Ratio 1.492
Current Ratio QoQ 4.873 %
Current Ratio YoY -20.399 %
Current Ratio IPRWA high: 5.013
mean: 2.82
median: 2.683
IFF: 1.492
low: 1.286
 Quick Ratio 0.841
Quick Ratio QoQ 2.456 %
Quick Ratio YoY -38.056 %
Quick Ratio IPRWA high: 1.966
median: 1.607
mean: 1.583
low: 0.865
IFF: 0.841
COVERAGE & LEVERAGE
 Debt To EBITDA 12.896
 Cost Of Debt 0.548 %
 Interest Coverage Ratio 5.75
Interest Coverage Ratio QoQ 296.831 %
Interest Coverage Ratio YoY -144.231 %
Interest Coverage Ratio IPRWA high: 24.733
mean: 9.414
IFF: 5.75
median: 4.847
low: -1.302
 Operating Cash Flow Ratio 0.108
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 71.378
DIVIDENDS
 Dividend Coverage Ratio 1.657
 Dividend Payout Ratio 0.604
 Dividend Rate 0.40
 Dividend Yield 0.006
PERFORMANCE GROWTH
 Asset Growth Rate -1.547 %
 Revenue Growth 5.871 %
Revenue Growth QoQ -250.616 %
Revenue Growth YoY 125.982 %
Revenue Growth IPRWA high: 24.87 %
mean: 11.182 %
median: 10.773 %
IFF: 5.871 %
low: -29.973 %
 Earnings Growth 56.25 %
Earnings Growth QoQ -336.245 %
Earnings Growth YoY 137.232 %
Earnings Growth IPRWA high: 250.0 %
IFF: 56.25 %
mean: 18.344 %
median: -18.269 %
low: -119.167 %
MARGINS
 Gross Margin 37.14 %
Gross Margin QoQ 8.04 %
Gross Margin YoY 2.019 %
Gross Margin IPRWA high: 40.607 %
median: 37.34 %
IFF: 37.14 %
mean: 36.132 %
low: 30.498 %
 EBIT Margin 9.23 %
EBIT Margin QoQ 236.616 %
EBIT Margin YoY -128.43 %
EBIT Margin IPRWA high: 23.954 %
mean: 13.484 %
median: 12.405 %
IFF: 9.23 %
low: -11.126 %
 Return On Sales (ROS) 10.179 %
Return On Sales QoQ 133.196 %
Return On Sales YoY -131.353 %
Return On Sales IPRWA high: 21.386 %
mean: 13.934 %
median: 13.262 %
IFF: 10.179 %
low: -7.473 %
CASH FLOW
 Free Cash Flow (FCF) 92.0 M
 Free Cash Flow Yield 0.501 %
Free Cash Flow Yield QoQ -31.837 %
Free Cash Flow Yield YoY -293.436 %
Free Cash Flow Yield IPRWA high: 1.666 %
IFF: 0.501 %
mean: -0.49 %
median: -1.064 %
low: -2.935 %
 Free Cash Growth -29.231 %
Free Cash Growth QoQ -108.769 %
Free Cash Growth YoY -76.615 %
Free Cash Growth IPRWA high: 305.601 %
IFF: -29.231 %
median: -203.667 %
mean: -251.237 %
low: -916.351 %
 Free Cash To Net Income 0.544
 Cash Flow Margin 14.374 %
 Cash Flow To Earnings 2.331
VALUE & RETURNS
 Economic Value Added 0.03
 Return On Assets (ROA) 0.667 %
Return On Assets QoQ 451.24 %
Return On Assets YoY -118.652 %
Return On Assets IPRWA high: 3.375 %
median: 1.949 %
mean: 1.511 %
IFF: 0.667 %
low: -2.945 %
 Return On Capital Employed (ROCE) 1.177 %
 Return On Equity (ROE) 0.012
Return On Equity QoQ 446.575 %
Return On Equity YoY -115.493 %
Return On Equity IPRWA high: 0.068
median: 0.031
mean: 0.012
IFF: 0.012
low: -0.154
 DuPont ROE 1.195 %
 Return On Invested Capital (ROIC) 1.032 %
Return On Invested Capital QoQ 271.223 %
Return On Invested Capital YoY -141.866 %
Return On Invested Capital IPRWA high: 4.674 %
mean: 2.127 %
median: 1.844 %
IFF: 1.032 %
low: -0.797 %

Six-Week Outlook

Technical alignment and recent portfolio actions support a constructive short-term bias: emerging directional strength (ADX ~23), DI+ dip-and-reversal, a bullish MACD crossover, and price trading above key moving averages favor additional upside toward the analyst price-target mean near $92. Near-term upside faces resistance at the upper Bollinger band (~$79–$84) and potential consolidation given the positive MRO reading. Fundamental drivers that will influence swing momentum include margin recovery against peer benchmarks and any further proceeds or announcements tied to portfolio disposals that reduce net debt. Positioning should anticipate short-term volatility given the elevated 42-day beta and watch for tightening or widening of the operating margin to validate further directional conviction.

About International Flavors & Fragrances Inc.

International Flavors & Fragrances Inc. (NYSE:IFF) creates innovative solutions that enhance consumer experiences through scents, tastes, and nutrition. Headquartered in New York City, IFF operates through four main segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment develops natural and plant-based ingredients that enrich flavors in a variety of food and beverage products. Health & Biosciences focuses on producing enzymes, probiotics, and specialty ingredients that support both food and non-food industries, emphasizing health and sustainability. In the Scent division, IFF crafts fragrance compounds, including fine perfumes, consumer fragrances, and essential oils, which enhance personal care and household products. Pharma Solutions delivers innovative cellulosics and seaweed-based excipients for the pharmaceutical industry. Since its founding in 1909, IFF has committed to blending artistry with science, serving a diverse range of markets worldwide. By collaborating with manufacturers in cosmetics, food, beverages, and pharmaceuticals, IFF continues to inspire consumers while advancing industry standards and prioritizing sustainable practices to enhance well-being globally.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.